aTyr Pharma, Inc.ATYRNASDAQ
Loading
Revenue ContractionContracting
Percentile Rank62
3Y CAGR-73.7%
5Y CAGR-55.1%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-73.7%/yr
Annual compound
5Y CAGR
-55.1%/yr
Recent deceleration
Percentile
P62
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $190000.00 | -19.1% |
| 2024 | $235000.00 | -33.4% |
| 2023 | $353000.00 | -96.6% |
| 2022 | $10.39M | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $10.46M | +2377.5% |
| 2019 | $422000.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |